Digoxinemia

Authors

  • Alvaro Apestegui Barzuna
  • Jorge Deliyore Romero

DOI:

https://doi.org/10.51481/amc.v38i1.609

Keywords:

Digoxine, digitalis, therapeutic drugs monitoring

Abstract

The use of digoxin as an adyuvant in cardiac therapy is discussed. Reference is also made to its mechanism of ac-
tion and to the different physiological and drug induced
mechanisms that could affect its bioavailability and absorp-
tion. Factors interfering with its quantification in body flu-
ids are also discussed and recommendations are issued in order to optimize the use of this measurement. Recommen-
ded therapeutic levels are also revised.

Downloads

Download data is not yet available.

References

AKERA, T. BRODY, TM.: THE ROLE OF NA+, K+-ATRASE IN THE !ONO-

TROPIC ACTION OF DIGITALIS. RHARMACOL. REV. 29:187-220 (1977).

MILLER J.J., STRAUB, R.W. JR. VALES, R. JR; DIGOXIN IMMUNOASSAY WITH

CROSS-REACTIVITY OF DIGOXIN METABOLITES PROPORTIONAL TO THE BIOLO-

GICAL ACTIVITY. CLIN. CHEM. 40:1898-1903. 1994.

LINDE.NBAUM, J., MELLOW, H.M., BLACKSTONE, M.O., BUTLER, V.P. JR.: VARIATION IN BIOLOGICAL AVAILABILITY OF DIGOXIN FROM FOUR PREPARA-

TIONS. N. ENGL. J. MED. 285:1344-1347 (1971).

HEIZER, W.D., SMITH T.W., GOLDFINGER, S.E.

ABSORPTION OF DIGOXIS IN PATIENTS WITH MALABSORPTION SYNDROMES, N.ENG. J. MED. 2855:257-259, 1971,

MANNINEN, V., Mari, J., APAJALAHII, A., /C RI:501A, M.: ALTERED AB-

SORPTION OF DIGOXIN IN PATIENTS GIVEN PROPARTHELINE AND METOCLOPRAMIDE. LANCET 1:398-400, 1973.

MAROKO, P.R., KjicsHus, J.K., SOBEL, B.E, WATANABE, T., ROSS, J.R.

JR., BRAUNWALD, E.; FACTORS INFLUENCING INFARCT SIZE FOLLOWING EXPE-

RIMENTAL CORONARY ARTERY COCLUSSIONS.. CIRCULATION43:67-82, 1971.

MOYER, T.P., BOECKX, R. L.: APPLIED THERAPEUTIC DRUG MONITORING. VOLUME II: REVIEW AND CASE STUDIES, AACC, 1984.

LAWRENCE, J.R., SUMNER, D. J., 'CALK, W.J. RATCKIFFE, W.A. WHITING, B., GRAY, K., LINDSAY, M.: DIGOXIN KINETICS IN PATIENTS WITH THYROID

DISFUNCTION. CLIN. PHARMACOL. THER. 22:7-13. 1977.

EJVINSSON, G.: EFFECT OF QUIN-MINE ON PLASMA CONCENTRATIONS OF

DIGOXIN, BR. MED. J. 1:279-280. 1978.

MUNGALL, ROBLOHALDC, R.P., PERRY, W. ET ALEEPECTS OF Qui-

NIDINE ON SERUM DIGOXIN CONCENTRATION: A PROSPECTIVE STUDY, ANN INTERN. MED. 93: 689-693, 1980.

JAcoas, D.S., KASTEN, B.L., DEN047, W.R. AND WOLFSON, W.E. LA-

BORATORY TEST HADBOOK. LEXICOMP INC./MOSBY, OHIO. 1988.

GRAVES, S.W., BROWN, B. AND VALUES, R. AN ENDOGENOUS DIGO-

XIN-LIKE SUBSTANCE IN PATIENTS WITH RENAL IMPAIRMENT. ANN. INTER. ME-

D.INTERN.MED. 99:604-608. 1983.

HALKIN, H. VALUE OF SERUM DIGOXIN CONCENTRATION MEASURMENT

IN THE CONTROL OF DIGOXIN TERAPY IN ATRIAL FIBRILLATION. ISE. J. ME.

Sot. 15: 490-493. 1979.

Downloads

Published

1996-12-01

How to Cite